McIver Explores Treatment of a Patient With RET-Mutated Medullary Thyroid Cancer
During a virtual Targeted Oncology Case-Based Roundtable event, Bryan McIver, MD, PhD, discussed the case of a 58-year-old patient with RET-mutant medullary thyroid cancer.